Results 11 to 20 of about 76,703 (258)

THE USE OF GLUCOSAMINE AND THE INCREASE OF IOP: A LITERATURE REVIEW

open access: yesMajalah Biomorfologi, 2022
Highlights: 1. There are differences in the result of the use of glucosamine and the increase of intraocular pressure. 2. There are many other factors that may contribute to the increase in the intraocular pressure other than the use of glucosamine ...
Wega Yusan Wira Perdana   +6 more
doaj   +1 more source

Anserine and glucosamine supplementation attenuates the levels of inflammatory markers in rats with rheumatoid arthritis

open access: yesAMB Express, 2020
Rheumatoid arthritis (RA) is an autoimmune disorder that affects the joint synovium. Anserine is a functional dipeptide containing methylhistidine and β-alanine, and is present in the brain and skeletal muscle of birds and mammals.
Jiang Minghao Zhao   +4 more
doaj   +1 more source

Health Technology Assessment of Different Glucosamine Formulations and Preparations Currently Marketed in Thailand

open access: yesMedicines, 2023
Objective: The aim of this study was to evaluate the cost-effectiveness of different glucosamine formulations and preparations used for the management of osteoarthritis in Thailand compared with placebo. Methods: We used a validated model to simulate the
Olivier Bruyère   +2 more
doaj   +1 more source

Review Article: Glucosamine [PDF]

open access: yesJournal of Orthopaedic Surgery, 2009
It has been claimed that glucosamine is able to alleviate pain, slow down losses of, and even restore articular cartilage in patients with damaged or osteoarthritic joints. It is classified as a food additive or nutraceutical; therefore manufacturers do not need to comply with the same regulations that apply for quality assurance within the ...
R K Samarasinghe, S G Kirkham
openaire   +3 more sources

Investigation of Drug-Interaction Potential for Arthritis Dietary Supplements: Chondroitin Sulfate, Glucosamine, and Methylsulfonylmethane

open access: yesMolecules, 2023
Osteoarthritis is one of the leading conditions that promote the consumption of these dietary supplements. Chondroitin sulfate, glucosamine, and methylsulfonylmethane are among the prominent alternative treatments for osteoarthritis. In this study, these
Su Min Kim   +5 more
doaj   +1 more source

Slt2 Is Required to Activate ER-Stress-Protective Mechanisms through TORC1 Inhibition and Hexosamine Pathway Activation

open access: yesJournal of Fungi, 2022
Slt2, the MAPK of the cell wall integrity (CWI) pathway, connects different signaling pathways and performs different functions in the protective response of S. cerevisiae to stress.
Isabel E. Sánchez-Adriá   +4 more
doaj   +1 more source

Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs

open access: yesСовременная ревматология, 2021
The effectiveness of combined drugs, consisting of chondroitin and glucosamine (GA) in the treatment of osteoarthritis (OA) is discussed. Due to their high safety and pleiotropic effects, these drugs can be used in patients with OA (primarily with ...
E. V. Zonova
doaj   +1 more source

UTILIZATION OF CRUSTASEAN SHELL WASTE FORPRODUCTION OF GLUCOSAMINE HYDROCHLORIDE (GlcN HCl) BY USING AUTOCLAVING METHOD

open access: yesJurnal Teknologi Perikanan dan Kelautan, 2015
Utilization of crustacean shell waste to produce chitosan could continue by derivatisation to producedglucosamine. Glucosamin hydrochloride (GlcN HCl) is one of the nutraceuticals product widely consumed for reducing osteoarthritis symptoms.
Pipih Suptija   +2 more
doaj   +1 more source

Symptomatic delayed-acting drugs (SYSADOA): new applications

open access: yesСовременная ревматология, 2022
The review systematizes modern data indicating effective pain control and a significant improvement in the functional activity of patients suffering from osteoarthritis (OA) using pharmaceutical substances of chondroitin sulfate (CS) and glucosamine (GA).
A. M. Lila   +3 more
doaj   +1 more source

Glucosamine and Leukemia.

open access: yesExperimental Biology and Medicine, 1953
SummaryHighly purified glucosamine at dose levels as high as 20 g per day for several days did not influence the course of one patient with acute lymphocytic, one with acute histiomonocytic, one with chronic myelocytic and 2 with chronic lymphocytic leukemias.
Grant R. Bartlett, Arthur A. Marlow
openaire   +3 more sources

Home - About - Disclaimer - Privacy